Evidence map›Paper›PMID 40502042›Full record

ArticlebioRxiv : the preprint server for biology2025

Non-Equilibrium Snapshots of Ligand Efficacy at the μ-Opioid Receptor.

Michael J Robertson, Makaía M Papasergi-Scott, Maria Claudia Peroto, Balazs R Varga, Susruta Majumdar, Georgios Skiniotis

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Michael J RobertsonDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-2610-680X
Makaía M Papasergi-ScottDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-3238-3213
Maria Claudia PerotoDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-4928-9381
Balazs R VargaCenter for Clinical Pharmacology, Department of Anesthesiology and Washington University Pain Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-0986-9477
Susruta MajumdarCenter for Clinical Pharmacology, Department of Anesthesiology and Washington University Pain Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-2931-3823
Georgios SkiniotisDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0238-7846

Funding

Efficacy and signaling modulation by targeting the sodium site at mu opioid receptorR01DA059978 · NIDA · WASHINGTON UNIVERSITY · PI Susruta Majumdar · 2024 to 2026
$1.8M
Improved Targeting of Somatostatin Receptors for Pediatric ConditionsR00HD107581 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI ROBERTSON, MICHAEL · 2024 to 2025
$411k
Improved Targeting of Somatostatin Receptors for Pediatric ConditionsK99HD107581 · NICHD · STANFORD UNIVERSITY · PI ROBERTSON, MICHAEL · 2022 to 2023
$244k
NICHD NIH HHS K99 HD107581NICHD NIH HHS R00 HD107581NIDA NIH HHS R01 DA059978
6 · The paper itself

Abstract

Distinct ligands for the same G-protein coupled receptor (GPCR) activate intracellular signaling partners to varying extents, but the molecular mechanisms driving these differences remains elusive. Hypothesizing that such differences in signaling efficacy may be captured structurally in intermediate states under non-equilibrium conditions, we implemented a time-resolved (TR) cryo-EM approach to visualize the GTP-induced activation of the Gαiβγ heterotrimer by the μ-opioid receptor (MOR) bound to three ligands displaying partial, full, or super-agonism on the receptor. We resolved ensembles of conformational states along the G-protein activation pathway, including a previously unobserved intermediate state that enabled us to visualize receptor dynamics as a function of bound ligand. The results demonstrate ligand-dependent differences in state occupancy and conformational stability, with higher ligand efficacy correlating with increased dynamics of the receptor's transmembrane (TM) helices 5 and 6. Furthermore, we identify key mechanistic differences in the GTP-induced activation of Gi compared to Gs that likely underlie their distinct activation kinetics. Corroborated by molecular dynamics (MD) simulations, these findings provide a dynamic structural landscape of GPCR-G-protein interactions for ligands of different efficacy and suggest partial agonists may produce a 'kinetic trap' during G-protein activation.

Identifiers

PMID40502042
PMCPMC12154725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.